LitCovid-sample-Enju  

PMC:7205724 / 188-496 JSONTXT 12 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T26 0-1 -COMMA- denotes ,
T27 2-10 VBN denotes combined
T28 11-15 IN denotes with
T29 16-29 NN denotes moderate-dose
T30 30-32 IN denotes of
T31 33-48 NNS denotes corticosteroids
T32 48-49 -COMMA- denotes ,
T33 50-55 MD denotes might
T34 56-63 VB denotes improve
T35 64-71 NN denotes patient
T36 72-80 NNS denotes outcomes
T37 82-83 PDT denotes •
T38 85-88 DT denotes The
T39 89-92 NN denotes use
T40 93-95 IN denotes of
T41 96-111 NNS denotes corticosteroids
T42 112-117 MD denotes might
T43 118-128 VB denotes accelerate
T44 129-137 NN denotes recovery
T45 138-142 IN denotes from
T46 143-151 NN denotes COVID-19
T47 153-154 PDT denotes •
T48 156-158 DT denotes No
T49 159-169 VBN denotes controlled
T50 170-178 JJ denotes clinical
T51 179-185 NNS denotes trials
T52 186-191 VBP denotes exist
T53 192-194 IN denotes on
T54 195-198 DT denotes the
T55 199-202 NN denotes use
T56 203-205 IN denotes of
T57 206-221 NNS denotes corticosteroids
T58 222-225 IN denotes for
T59 226-234 NN denotes COVID-19
T60 236-237 LS denotes •
T61 239-242 NN denotes IL6
T62 243-253 VBZ denotes correlates
T63 254-258 IN denotes with
T64 259-267 NN denotes severity
T65 267-268 -COMMA- denotes ,
T66 269-280 NN denotes criticality
T67 280-281 -COMMA- denotes ,
T68 282-287 JJ denotes viral
T69 288-292 NN denotes load
T70 292-293 -COMMA- denotes ,
T71 294-297 CC denotes and
T72 298-307 NN denotes prognosis
R23 T27 T28 arg1Of combined,with
R24 T29 T28 arg2Of moderate-dose,with
R25 T29 T30 arg1Of moderate-dose,of
R26 T31 T30 arg2Of corticosteroids,of
R27 T34 T32 arg1Of improve,","
R29 T34 T33 arg2Of improve,might
R31 T36 T34 arg2Of outcomes,improve
R32 T36 T35 arg1Of outcomes,patient
R33 T39 T37 arg1Of use,•
R34 T39 T38 arg1Of use,The
R35 T39 T40 arg1Of use,of
R36 T41 T40 arg2Of corticosteroids,of
R37 T39 T42 arg1Of use,might
R38 T43 T42 arg2Of accelerate,might
R39 T39 T43 arg1Of use,accelerate
R40 T44 T43 arg2Of recovery,accelerate
R41 T44 T45 arg1Of recovery,from
R42 T46 T45 arg2Of COVID-19,from
R43 T51 T47 arg1Of trials,•
R44 T51 T48 arg1Of trials,No
R45 T51 T49 arg2Of trials,controlled
R46 T51 T50 arg1Of trials,clinical
R47 T51 T52 arg1Of trials,exist
R48 T52 T53 arg1Of exist,on
R49 T55 T53 arg2Of use,on
R50 T55 T54 arg1Of use,the
R51 T55 T56 arg1Of use,of
R52 T57 T56 arg2Of corticosteroids,of
R53 T55 T58 arg1Of use,for
R54 T59 T58 arg2Of COVID-19,for
R55 T62 T60 arg1Of correlates,•
R56 T61 T62 arg1Of IL6,correlates
R57 T62 T63 arg1Of correlates,with
R58 T71 T63 arg2Of and,with
R59 T64 T65 arg1Of severity,","
R60 T66 T65 arg2Of criticality,","
R61 T65 T67 arg1Of ",",","
R62 T69 T67 arg2Of load,","
R63 T69 T68 arg1Of load,viral
R64 T71 T70 arg1Of and,","
R65 T67 T71 arg1Of ",",and
R66 T72 T71 arg2Of prognosis,and